CompletedNCT01060787

Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bausch & Lomb Incorporated
Principal Investigator
Johnson Varughese, PA
Valeant Pharmaceuticals/Bausch & Lomb
Intervention
Fluocinolone Acetonide 0.59 mg(procedure)
Enrollment
98 target
Eligibility
6 years · All sexes
Timeline
20162019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01060787 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials